Bazedoxifene is a selective estrogen receptor modulator developed by Wyeth Pharmaceuticals, undergoing clinical evaluation for the prevention and treatment of postmenopausal osteoporosis. It is presently in the early phases of review by the United States' Food and Drug Administration.
The combination of the selective estrogen receptor modulator Bazedoxifene and conjugated estrogens may be an effective alternative to traditional hormone therapy for postmenopausal symptoms, according to...
| Currently you cannot purchase Basedoxifene as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Basedoxifene |
| Basedoxifene Availability Subscription Form |
|
| |
| Note: We will email you when Basedoxifene is available for sale online or in pharmacy in your country. |
|
|
|